Schwarz Pharma To Market Elan Verelan PM In Early 1999
Executive Summary
Schwarz Pharma expects to begin marketing Elan's Verelan PM by early 1999, Elan Chief Financial Officer Tom Lynch said Oct. 6 at the Warburg Dillon Read analyst conference in New York City.
You may also be interested in...
Ligand Avinza Co-promotion Deal Adds 700 Reps; Goal Is 10% Share By 2008
Ligand's Avinza co-promotion agreement with Organon adds more than 700 reps to detail the extended-release morphine product
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011